基本统计
| LEI | XDFJ0CYCOO1FXRFTQS51 |
| CIK | 904868 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Fresenius SE & Co. KGaA - Depositary Receipt (Common Stock)
SEC Filings (Chronological Order)
本页提供了美国证券交易委员会（SEC）备案的完整、按时间顺序排列的列表，不包括我们在其他地方提供的所有权备案。
| December 7, 2023 |
FMS / Fresenius Medical Care AG - ADR / Fresenius SE & Co. KGaA - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 9) FRESENIUS MEDICAL CARE AG (Name of Issuer) Ordinary Shares without par value (Title of Class of Securities) 358029 10 61 (CUSIP Number) Matthias Fenner, Esq. Fresenius SE & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg v.d.H. Germany +49-6172-608-2327 C |
|
| March 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8) FRESENIUS MEDICAL CARE AG & CO. KGaA (Name of Issuer) Ordinary Shares without par value (Title of Class of Securities) 358029 10 61 (CUSIP Number) Matthias Fenner, Esq. Fresenius SE & Co. KGaA Else-Kröner-Straße 1 61352 Bad Homburg v.d.H. Germany +49-6172 |
|
| January 8, 2019 |
AKRX / Akorn, Inc. / Fresenius SE & Co. KGaA - SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Akorn, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 009728106 (CUSIP Number) Jack C. Silhavy c/o Fresenius Kabi USA, LLC Three Corporate Drive Lake Zurich, Illinois 60047 +1 847 550 2760 (Tel) +1 847 550 2920 (Fax) With |
|
| May 4, 2017 |
Exhibit 2.5 VOTING AGREEMENT dated as of April 24, 2017 (this “Agreement”), among FRESENIUS KABI AG, a German stock corporation (“Parent”), and each of THE INDIVIDUALS AND OTHER PARTIES LISTED ON SCHEDULE A ATTACHED HERETO (each, a “Shareholder” and, collectively, the “Shareholders”). WHEREAS Parent, Quercus Acquisition, Inc., a Louisiana corporation and a wholly owned subsidiary of Parent (“Merge |
|
| May 4, 2017 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER By and Among FRESENIUS KABI AG, QUERCUS ACQUISITION, INC., AKORN, INC. and FRESENIUS SE & CO. KGAA (solely for purposes of Article VIII) Dated as of April 24, 2017 TABLE OF CONTENTS Page ARTICLE I The Merger SECTION 1.01. The Merger 2 SECTION 1.02. Closing 2 SECTION 1.03. Effective Time 2 SECTION 1.04. Effects of the Merger 2 SECTION 1.05. Articles of Incor |
|
| May 4, 2017 |
EX-99.1 7 a17-124541ex99d1.htm EX-99.1 EXHIBIT 99.1 JOINT FILING AGREEMENT The undersigned hereby agree that they are filing this Schedule 13D jointly pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended (the Act). Each of them is responsible for the timely filing of such Schedule 13D and any amendments thereto and for the completeness and accuracy of the information |
|
| May 4, 2017 |
Exhibit 2.4 VOTING AGREEMENT dated as of April 24, 2017 (this “Agreement”), among FRESENIUS KABI AG, a German stock corporation (“Parent”), and each of THE INDIVIDUALS AND OTHER PARTIES LISTED ON SCHEDULE A ATTACHED HERETO (each, a “Shareholder” and, collectively, the “Shareholders”). WHEREAS Parent, Quercus Acquisition, Inc., a Louisiana corporation and a wholly owned subsidiary of Parent (“Merge |
|
| May 4, 2017 |
Exhibit 2.3 VOTING AGREEMENT dated as of April 24, 2017 (this “Agreement”), among FRESENIUS KABI AG, a German stock corporation (“Parent”), and each of THE INDIVIDUALS AND OTHER PARTIES LISTED ON SCHEDULE A ATTACHED HERETO (each, a “Shareholder” and, collectively, the “Shareholders”). WHEREAS Parent, Quercus Acquisition, Inc., a Louisiana corporation and a wholly owned subsidiary of Parent (“Merge |
|
| May 4, 2017 |
Exhibit 2.2 VOTING AGREEMENT dated as of April 24, 2017 (this “Agreement”), among FRESENIUS KABI AG, a German stock corporation (“Parent”), and each of THE INDIVIDUALS AND OTHER PARTIES LISTED ON SCHEDULE A ATTACHED HERETO (each, a “Shareholder” and, collectively, the “Shareholders”). WHEREAS Parent, Quercus Acquisition, Inc., a Louisiana corporation and a wholly owned subsidiary of Parent (“Merge |
|
| May 4, 2017 |
AKRX / Akorn, Inc. / Fresenius SE & Co. KGaA - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* Akorn, Inc. (Name of Issuer) Common Stock, no par value (Title of Class of Securities) 009728106 (CUSIP Number) Jack C. Silhavy c/o Fresenius Kabi USA, LLC Three Corporate Drive Lake Zurich, Illinois 60047 +1 847 550 2760 (Tel) +1 847 550 2920 (Fax) With |
|
| July 22, 2014 |
AMENDMENT TO DEPOSIT AGREEMENT AMENDMENT TO DEPOSIT AGREEMENT AMENDMENT dated as of August , 2014 (the "Amendment") to the Deposit Agreement dated as of October 26, 2011 (the "Deposit Agreement") among (i) Fresenius SE & Co. |
|
| July 22, 2014 |
F-6 POS 1 e612536f6pos-fresenius.htm As filed with the United States Securities and Exchange Commission on July 22, 2014 333-177379 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FOR AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS Fresenius SE & Co. KGaA |
|
| July 22, 2014 |
Certification under Rule 466 The depositary, Deutsche Bank Trust Company Americas, represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (Fresenius SE & Co. |
|
| March 1, 2012 |
Fresenius SE & Co. KGaA - AMENDMENT NO. 7 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7) FRESENIUS MEDICAL CARE AG & CO. KGaA (Name of Issuer) Ordinary Shares without par value (Title of Class of Securities) 358029 10 6 (CUSIP Number) Robert A. Grauman, Esq. Baker & McKenzie LLP 1114 Avenue of the Americas New York NY 10036 (Name, Address and |
|
| February 16, 2012 |
Fresenius SE & Co. KGaA - SCHEDULE 13D/A 6 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 6) FRESENIUS MEDICAL CARE AG & CO. KGaA (Name of Issuer) Ordinary Shares without par value (Title of Class of Securities) 358029 10 6 (CUSIP Number) Robert A. Grauman, Esq. Baker & McKenzie LLP 1114 Avenue of the Americas New York NY 10036 (Name, Address and |
|
| November 16, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 5) FRESENIUS MEDICAL CARE AG & CO. KGaA (Name of Issuer) Ordinary Shares without par value (Title of Class of Securities) 358029 10 6 (CUSIP Number) Robert A. Grauman, Esq. Baker & McKenzie LLP 1114 Avenue of the Americas New York NY 10036 (Name, Address and |
|
| October 19, 2011 |
Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, 44th Floor New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 October 19, 2011 Deutsche Bank Trust Company Americas, as Depositary 60 Wall Street New York, New York 10005 American Depositary Shares evidenced by American Depositary Receipts for deposited ordinary shares Fresenius SE & Co. |
|
| October 19, 2011 |
As filed with the United States Securities and Exchange Commission on October 19, 2011 F-6 1 e608998f6-fresenius.htm As filed with the United States Securities and Exchange Commission on October 19, 2011 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FOR AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS Fresenius SE & Co. KGaA (Exact name of issuer of deposited securities as |
|
| October 19, 2011 |
DEPOSIT AGREEMENT by and among FRESENIUS SE & CO. KGAA AND DEUTSCHE BANK TRUST COMPANY AMERICAS as Depositary, AND THE HOLDERS AND BENEFICIAL OWNERS OF AMERICAN DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS ISSUED HEREUNDER Dated as of October , 2011 DEPOSIT AGREEMENT DEPOSIT AGREEMENT, dated as of October , 2011, by and among (i) Fresenius SE & Co. KGaA, a partnership limited by sha |
|
| August 19, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 4) FRESENIUS MEDICAL CARE AG & CO. KGaA (Name of Issuer) Ordinary Shares without par value (Title of Class of Securities) 358029 10 6 (CUSIP Number) Robert A. Grauman, Esq. Baker & McKenzie LLP 1114 Avenue of the Americas New York NY 10036 (Name, Address and |
|
| February 4, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3) FRESENIUS MEDICAL CARE AG & CO. KGaA (Name of Issuer) Ordinary Shares without par value (Title of Class of Securities) 358029 10 6 (CUSIP Number) Charles F. Niemeth, Esq. Baker & McKenzie LLP 1114 Avenue of the Americas New York NY 10036 (Name, Address an |
|
| July 29, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) FRESENIUS MEDICAL CARE AG & CO. KGaA (Name of Issuer) Ordinary Shares without par value (Title of Class of Securities) 358029 10 6 (CUSIP Number) Charles F. Niemeth, Esq. Baker & McKenzie LLP 1114 Avenue of the Americas New York NY 10036 (Name, Address an |
